Literature DB >> 33489066

Systematic review: the impact of inflammatory bowel disease-related fatigue on health-related quality of life.

Shellie Jean Radford1,2, Jordan McGing2, Wladyslawa Czuber-Dochan3, Gordon Moran1,2.   

Abstract

BACKGROUND: Fatigue is frequently reported in inflammatory bowel disease (IBD) and impacts on health-related quality of life (HRQoL). HRQoL has not been systematically reviewed in IBD fatigue. AIM: To investigate what impact IBD fatigue has on HRQoL in adults with IBD.
METHODS: Systematic searches (CINAHL, EMBASE, PsychINFO, Medline) were conducted on 25 September 2018, restricted to 'human', 'adult', 'primary research' and 'English language'. Search terms encompassed concepts of 'fatigue', 'IBD' and 'HRQoL'. A 5-year time limit (2013-2018) was set to include the most relevant publications. Publications were screened, data extracted and quality appraised by two authors. A narrative synthesis was conducted.
RESULTS: Eleven studies were included, presenting data from 2823 participants. Fatigue experiences were significantly related to three HRQoL areas: symptom acceptance, psychosocial well-being and physical activity. Patients reporting high fatigue levels had low symptom acceptance. Psychosocial factors were strongly associated with both fatigue and HRQoL. Higher social support levels were associated with higher HRQoL. Physical activity was impaired by higher fatigue levels, lowering HRQoL, but it was also used as a means of reducing fatigue and improving HRQoL. Quality appraisal revealed methodological shortcomings in a number of studies. Notably, use of multiple measures, comparison without statistical adjustment and fatigue and HRQoL assessment using the same tool were some of the methodological shortcomings.
CONCLUSION: Psychosocial factors, symptom management and acceptance and physical activity levels have significant impact on HRQoL. Results support application of psychosocial or exercise interventions for fatigue management. Further exploration of HRQoL factors in IBD fatigue is required, using validated fatigue and HRQoL measures. PROSPERO REGISTRATION NUMBER: CRD42018110005. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Crohn’s disease; fatigue; health related quality of life; inflammatory bowel disease; ulcerative colitis

Year:  2020        PMID: 33489066      PMCID: PMC7802486          DOI: 10.1136/flgastro-2019-101355

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  64 in total

Review 1.  Systematic review: fatigue in inflammatory bowel disease.

Authors:  D R van Langenberg; P R Gibson
Journal:  Aliment Pharmacol Ther       Date:  2010-05-06       Impact factor: 8.171

2.  The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model.

Authors:  Jennifer Devlen; Kathleen Beusterien; Linnette Yen; Awais Ahmed; Adam S Cheifetz; Alan C Moss
Journal:  Inflamm Bowel Dis       Date:  2014-03       Impact factor: 5.325

3.  Quality of life in patients with inflammatory bowel disease: importance of clinical, demographic and psychosocial factors.

Authors:  Joana Magalhães; Francisca Dias de Castro; Pedro Boal Carvalho; Maria João Moreira; José Cotter
Journal:  Arq Gastroenterol       Date:  2014 Jul-Sep

Review 4.  Psychosocial aspects of inflammatory bowel disease.

Authors:  J Casati; B B Toner
Journal:  Biomed Pharmacother       Date:  2000-08       Impact factor: 6.529

Review 5.  Review article: psychosocial factors in the quality of life of patients with inflammatory bowel disease.

Authors:  A Sainsbury; R V Heatley
Journal:  Aliment Pharmacol Ther       Date:  2005-03-01       Impact factor: 8.171

Review 6.  Review article: Description and management of fatigue in inflammatory bowel disease.

Authors:  W Czuber-Dochan; E Ream; C Norton
Journal:  Aliment Pharmacol Ther       Date:  2013-01-13       Impact factor: 8.171

7.  Identifying disease-specific distress in patients with inflammatory bowel disease.

Authors:  Sue Woodward; Lesley Dibley; Sarah Coombes; Andrew Bellamy; Calum Clark; Wladyslawa Czuber-Dochan; Leslie Everelm; Sandra Kutner; Jackie Sturt; Christine Norton
Journal:  Br J Nurs       Date:  2016-06-23

Review 8.  The assessment of fatigue: a practical guide for clinicians and researchers.

Authors:  A J Dittner; S C Wessely; R G Brown
Journal:  J Psychosom Res       Date:  2004-02       Impact factor: 3.006

9.  Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns.

Authors:  D A Drossman; D L Patrick; C M Mitchell; E A Zagami; M I Appelbaum
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

10.  What Are the Top 10 Research Questions in the Treatment of Inflammatory Bowel Disease? A Priority Setting Partnership with the James Lind Alliance.

Authors:  Ailsa L Hart; Miranda Lomer; Azmina Verjee; Karen Kemp; Omar Faiz; Ann Daly; Julie Solomon; John McLaughlin
Journal:  J Crohns Colitis       Date:  2016-08-09       Impact factor: 9.071

View more
  1 in total

1.  Role of thigh circumference, calf circumference, subjective global assessment, and handgrip strength as diagnostic modalities of sarcopenia in women inflammatory bowel disease patients.

Authors:  Rabbinu Rangga Pribadi; Marcellus Simadibrata; Andri Sanityoso Sulaiman; Murdani Abdullah
Journal:  JGH Open       Date:  2022-07-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.